A practical approach to screening for carbapenemase-producing Enterobacterales– views of a group of multidisciplinary experts from English hospitals.

Autor: Jenkins, DR., Auckland, C., Chadwick, C., Dodgson, AR., Enoch, DA., Goldenberg, SD., Hussain, A., Martin, J., Spooner, E., Whalley, T.

Publikováno v: BMC Infectious Diseases; 4/26/2024, Vol. 24 Issue 1, p1-9, 9p

The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in 7 NHS secondary care hospitals in England: a series of local service evaluations

Autor: Goldenberg, SD, Brown, S, Edwards, L, Gnanarajah, D, Howard, P, Jenkins, D, Nayar, D, Pasztor, M, Oliver, S, Planche, T, Sandoe, JAT, Wade, P, Whitney, L

Purpose. C. difficile infection (CDI) is associated with high mortality. Reducing incidence is a priority for patients, clinicians, the NHS and Public Health England alike. In June 2012 fidaxomicin (FDX) was launched for the treatment of adults with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ef76502893d1c97505c051a471a72e30
https://eprints.whiterose.ac.uk/92477/8/a-2538-z.pdf

Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England.

Autor: Goldenberg SD, French GL

Publikováno v: Journal of Hospital Infection; Sep2011, Vol. 79 Issue 1, p4-7, 4p

Use of a peracetic acid (PAA) disinfectant to reduce total viable bacteria count in hospital wastewater drains.

Autor: Sharrocks K; Department of Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Prossomariti D; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK., Snell LB; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College, London, UK., Dibbens M; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK., Alcolea-Medina A; Synnovis Analytics LLP, London, UK., Gargee L; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK., Marashi J; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK., Edgeworth JD; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College, London, UK., Otter JA; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK., Goldenberg SD; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, London, UK; Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College, London, UK. Electronic address: Simon.goldenberg@gstt.nhs.uk.

Publikováno v: The Journal of hospital infection [J Hosp Infect] 2024 Sep; Vol. 151, pp. 79-83. Date of Electronic Publication: 2024 Jun 29.

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

Autor: Mullish BH; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK., Merrick B; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK., Quraishi MN; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, London, UK., Bak A; Healthcare Infection Society, London, UK., Green CA; Department of Infectious Diseases & Tropical Medicine, University Hospitals NHS Foundation Trust, Birmingham Heartlands Hospital, Birmingham, UK.; School of Chemical Engineering, University of Birmingham, Birmingham, UK., Moore DJ; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK., Porter RJ; Department of Microbiology, Royal Devon and Exeter Hospitals, Barrack Road, UK., Elumogo NT; Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.; Norfolk and Norwich University Hospital, Norwich, UK., Segal JP; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Sharma N; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, London, UK., Marsh B; Lay representative for FMT Working Party, Healthcare Infection Society, London, UK., Kontkowski G; Lay representative for FMT Working Party, Healthcare Infection Society, London, UK.; C.diff support, London, UK., Manzoor SE; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK., Hart AL; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.; Department of Gastroenterology and Inflammatory Bowel Disease Unit, St Mark's Hospital and Academic Institute, Middlesex, UK., Settle C; South Tyneside and Sunderland NHS Foundation Trust, South Shields, UK., Keller JJ; Department of Gastroenterology, Haaglanden Medisch Centrum, The Hague, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands., Hawkey P; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Public Health Laboratory, Faculty of Medicine, University of Birmingham, Birmingham, UK., Iqbal TH; Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Microbiome Treatment Centre, University of Birmingham, Edgbaston, UK.; Institute of Cancer and Genomic Sciences, University of Birmingham, London, UK., Goldenberg SD; Centre for Clinical Infection and Diagnostics Research, Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK h.williams@imperial.ac.uk Simon.Goldenberg@gstt.nhs.uk., Williams HRT; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK h.williams@imperial.ac.uk Simon.Goldenberg@gstt.nhs.uk.; Departments of Gastroenterology and Hepatology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.

Publikováno v: Gut [Gut] 2024 Jun 06; Vol. 73 (7), pp. 1052-1075. Date of Electronic Publication: 2024 Jun 06.